Based in Manhasset, N.Y., BML Pharmaceuticals, Inc. researches and develops proprietary prescriptive pharmaceutical products in the areas of cancer treatment, and infectious and inflammatory diseases. BML's products are formulated into therapeutics that range from the prevention and treatment of dermal disease to the severely debilitating mucositis that is a major dose-limiting factor in radiation and chemotherapy treatment for cancer patients.
